Stay updated on Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page now communicates that recruitment is closed and adds user-help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with Intervention/Treatment; the site version updates to v3.6.0, and the older label 'Intervention / Treatment' and revision note v3.5.5 are removed.SummaryDifference0.4%

- Check8 days agoChange DetectedRevision: v3.5.5 is now displayed, replacing Revision: v3.5.4. This appears to be a minor site update rather than a modification of the study details or study results.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the study details page, reflecting a minor administrative update to the page version. This does not alter the underlying study data or content.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page’s footer/version indicator has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a content system release without altering the study record details.SummaryDifference0.1%

- Check58 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check87 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page.SummaryDifference0.1%

Stay in the know with updates to Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.